FAQs
What are ROVI's activities in the pharmaceutical market at present?
In which pharmaceutical areas is ROVI present?
What are the main factors in ROVI’s strategy?
News
First quarter 2023 results press release
ROVI REACHED 201.9 MILLION EUROS OF REVENUE IN THE FIRST POST-PANDEMIC QUARTER
ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE)
ROVI COMMENCES CLINICAL DEVELOPMENT OF A NEW THREE-MONTHLY FORMULATION OF LETROZOLE (LETROZOLE LEBE)
Contact
At ROVI, we have a policy of transparency and direct communication. Therefore, you may contact us directly whenever you need to do so.
ROVI
Head Offices
Julián Camarillo 35
28037 Madrid - Spain
28037 Madrid - Spain
Tel +(34) 91 375 62 30
Fax +(34) 91 375 62 30
Email: rovi@rovi.es